Literature DB >> 18073413

The role of matrix metalloproteinases in stromal/epithelial interactions in the gut.

N Sengupta1, T T MacDonald.   

Abstract

The gastrointestinal mucosa is an extremely soft, highly vascularised tissue, with a single layer of epithelium separating the gut lumen from the host. Epithelial cells adhere to a thin basement membrane that is produced by both epithelial cells and the underlying stromal cells. Signals passing between epithelial cells and stromal cells are needed for normal gut structure. In gut diseases, however, epithelial cells and stromal cells produce large amounts of matrix degrading enzymes (matrix metalloproteinases), the function of which is only beginning to be elucidated. Here, we review the role of matrix metalloproteonases (MMPs) in the gut in health, in gut inflammation, and in cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18073413     DOI: 10.1152/physiol.00027.2007

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN: 1548-9221


  29 in total

Review 1.  New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease.

Authors:  Darla R Shores; David G Binion; Bruce A Freeman; Paul R S Baker
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

Review 2.  Gastrointestinal mucositis: the role of MMP-tight junction interactions in tissue injury.

Authors:  Noor Al-Dasooqi; Hannah R Wardill; Rachel J Gibson
Journal:  Pathol Oncol Res       Date:  2014-01-15       Impact factor: 3.201

3.  Selective MMP Inhibition, Using AZD3342, to Reduce Gastrointestinal Toxicity and Enhance Chemoefficacy in a Rat Model.

Authors:  Rachel J Gibson; Ysabella Z A van Sebille; Hannah R Wardill; Anthony Wignall; Joseph Shirren; Imogen A Ball; Nicole Williams; Kiara Wanner; Joanne M Bowen
Journal:  Chemotherapy       Date:  2019-02-07       Impact factor: 2.544

4.  Clinically compatible flexible wide-field multi-color fluorescence endoscopy with a porcine colon model.

Authors:  Gyugnseok Oh; Youngrong Park; Su Woong Yoo; Soonjoo Hwang; Alexey V Dan Chin-Yu; Yeon-Mi Ryu; Sang-Yeob Kim; Eun-Ju Do; Ki Hean Kim; Sungjee Kim; Seung-Jae Myung; Euiheon Chung
Journal:  Biomed Opt Express       Date:  2017-01-10       Impact factor: 3.732

Review 5.  Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target.

Authors:  Eleonore Fröhlich
Journal:  Cell Mol Life Sci       Date:  2010-08-05       Impact factor: 9.261

6.  Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer.

Authors:  Bohee Jang; Hyejung Jung; Sojoong Choi; Young Hun Lee; Seung-Taek Lee; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2017-08-16       Impact factor: 5.157

7.  High expression of BAG3 predicts a poor prognosis in human medulloblastoma.

Authors:  Dong Yang; Ji Zhou; Hao Wang; Yutao Wang; Ge Yang; Yundong Zhang
Journal:  Tumour Biol       Date:  2016-07-25

8.  BAG3 regulates epithelial-mesenchymal transition and angiogenesis in human hepatocellular carcinoma.

Authors:  Heng Xiao; Shaobing Cheng; Rongliang Tong; Zheng Lv; Chaofeng Ding; Chengli Du; Haiyang Xie; Lin Zhou; Jian Wu; Shusen Zheng
Journal:  Lab Invest       Date:  2013-12-23       Impact factor: 5.662

9.  Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression.

Authors:  Jessica Bauer; Gerhard Liebisch; Claudia Hofmann; Christian Huy; Gerd Schmitz; Florian Obermeier; Jürgen Bock
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

10.  MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.

Authors:  George Fountzilas; Anna Kalogera-Fountzila; Sophia Lambaki; Ralph M Wirtz; Angelos Nikolaou; Georgia Karayannopoulou; Mattheos Bobos; Vassiliki Kotoula; Samuel Murray; Alexandros Lambropoulos; Gerasimos Aravantinos; Konstantinos Markou; Eleni Athanassiou; Despina Misailidou; Konstantine T Kalogeras; Demosthenis Skarlos
Journal:  J Oncol       Date:  2009-12-29       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.